
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
Musicians risk such afflictions as "guitar nipple" or "fiddler's neck" because of playing their instruments, a new dermatology study has reported.